-+ 0.00%
-+ 0.00%
-+ 0.00%

Merck Ventures-backed ReproNovo named to Fierce Biotech’s 2026 “Fierce 15” list

PUBT·10/05/2026 14:36:28
Listen to the news
Merck Ventures-backed ReproNovo named to Fierce Biotech’s 2026 “Fierce 15” list
  • Merck Ventures BV portfolio company ReproNovo was named to Fierce Biotech’s 2026 “Fierce 15” list of private biotech companies.
  • The recognition highlights ReproNovo’s work in fertility and women’s health, raising its profile with investors and potential partners.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck Ventures BV published the original content used to generate this news brief on October 05, 2026, and is solely responsible for the information contained therein.